Axonics, Inc. (Nasdaq: AXNX)


Engel Law PLLC is investigating whether fair value to Axonics, Inc. (Nasdaq: AXNX) shareholders will result from the proposed acquisition of Axonics by Boston Scientific Corporation (NYSE: BSX) for $71.00 in cash for each Axonics share.

The Firm’s investigation concerns:

(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Join this Action

Axonics, Inc.

MM slash DD slash YYYY